Cargando…
Plasmatic level of neurosin predicts outcome of mild cognitive impairment
BACKGROUND: Mild Cognitive Impairment (MCI) is a disorder considered to be a transitional stage from health to dementia. Diagnosis of dementias at these early stages is always troublesome because the pathophysiologic events leading to dementia precede clinical symptoms. Thus, the development of biom...
Autores principales: | Menendez-Gonzalez, Manuel, Castro-Santos, Patricia, Calatayud, Maria Teresa, Perez-Piñera, Pablo, Ribacoba, Renee, Martinez-Rivera, Marta, Gutierrez, Carmen, Lopez-Muñiz, Alfonso, Suarez, Ana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475518/ https://www.ncbi.nlm.nih.gov/pubmed/18620574 http://dx.doi.org/10.1186/1755-7682-1-11 |
Ejemplares similares
-
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
por: Wennström, Malin, et al.
Publicado: (2013) -
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
por: Spencer, Brian, et al.
Publicado: (2015) -
Plasmatic markers in hemorrhagic stroke
por: Marginean, IC, et al.
Publicado: (2011) -
Alterations in postmenopausal plasmatic lipidome
por: Nogueira, Iara Antonia Lustosa, et al.
Publicado: (2018) -
Production of Plasmatic Cell Juices—Experiments in Immunization and Clinical Treatment with the Plasmatic Cell Juices of Bacteria
Publicado: (1898)